Small Molecule based Drug Discovery using Machine Learning

We outline a process for building particular kinds of neural networks made up of structures that are intimately related to the structure of the molecule being studied. A cellular neural network can be programmed to solve a special neural connection problem that represents a molecule. which a cellular neural network can be trained using. The concept involved converting chemical structures, such as peptides or tiny organic compounds, into a RNN-based self-learning environment. In order to find and create novel drugs to treat illnesses and enhance human health, the discipline of drug discovery is crucial. It entails a difficult, multidisciplinary process that combines several scientific and technological viewpoints. Machine learning techniques have become effective instruments in the drug discovery process, providing chances to speed up and enhance efficiency. For activities like virtual screening, predictive modeling of compound attributes, optimization of drug candidates, and discovery of new therapeutic targets, machine learning techniques can be used. By easing data processing, offering insights into intricate biological systems, and directing experimental decision-making, these methods have the potential to shorten the time and expense associated with the drug development process. They can aid in the selection of candidates that have a greater chance of success, minimizing the number of substances that must be synthesized and tested experimentally by doing this process we can get results much faster then traditional drug discovery methods.